Advertisement
UK markets open in 1 hour 26 minutes

  • NIKKEI 225

    38,254.15
    +51.78 (+0.14%)
     

  • HANG SENG

    18,525.61
    +211.75 (+1.16%)
     

  • CRUDE OIL

    79.44
    +0.45 (+0.57%)
     

  • GOLD FUTURES

    2,324.60
    +2.30 (+0.10%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • Bitcoin GBP

    49,212.71
    -962.43 (-1.92%)
     

  • CMC Crypto 200

    1,311.66
    +16.99 (+1.31%)
     

  • NASDAQ Composite

    16,302.76
    -29.80 (-0.18%)
     

  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

Why Shares of Akebia Therapeutics Were Up Tuesday

Jim Halley, The Motley Fool
·2-min read
Why Shares of Akebia Therapeutics Were Up Tuesday

Shares of Akebia Therapeutics (NASDAQ: AKBA) were up more than 10% Tuesday after rising to as high as 13.1% in early trading. The biopharmaceutical company, which specializes in therapies to fight kidney disease, has seen its shares climb more than 168% so far this year. On Monday, the company announced that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) had granted marketing approval for Vafseo (vadadustat) to treat anemia connected with chronic kidney disease in adults on maintenance dialysis.

Continue reading